E3 Ubiquitin Ligase Ring Finger Protein 2 Alleviates Cerebral Ischemia–Reperfusion Injury by Stabilizing Mesencephalic Astrocyte‐Derived Neurotrophic Factor Through Monoubiquitination
CNS Neuroscience & Therapeutics · 2024
DOI: 10.1111/cns.70136 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2024. Verfasst von Yujun Shen und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Anhui Medical University, Hefei, China. Hauptthemen laut MEDLINE: Ubiquitination, Reperfusion Injury, Ubiquitin-Protein Ligases, Rats, Sprague-Dawley. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Research Fund of Anhui Institute of translational medicine, Joint Fund of the National Natural Science Foundation of China.
Abstract (Originalsprache)
Aim
Cerebral ischemic stroke (IS) is one of the leading causes of morbidity and mortality globally. However, the mechanisms underlying IS injury remain poorly understood. Ring finger protein 2 (RNF2), the member of the polycomb family (PcG), has been implicated in diverse biological and pathological conditions. However, whether RNF2 plays a role in IS progression is not clarified. This study aims to investigate the potential effects of RNF2 on IS.
Methods
The effects of RNF2 were studied in human postmortem IS brains, a rat model of IS, tunicamycin (TM)‐induced mouse neuroblastoma neuro2a (N2a) cells, and oxygen–glucose deprivation/reperfusion (OGD/R)‐induced SH‐SY5Y cells.
Results
Here, we demonstrated that RNF2 was markedly upregulated both in human postmortem IS brains and ischemic rat brains and RNF2 overexpression alleviated brain injury induced by middle cerebral artery occlusion by reducing neuron apoptosis. Mechanistically, we found that RNF2 is an E3 ubiquitin ligase for the mesencephalic astrocyte‐derived neurotrophic factor (MANF), which confers protection against brain ischemia. RNF2 interacted with MANF and promoted the monoubiquitination of MANF, consequently facilitating its stability and nuclear localization.
Conclusion
Collectively, RNF2 is identified as a critical inhibitor of IS injury by stabilizing MANF through monoubiquitination, suggesting that RNF2 is a potential therapeutic target for IS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medical Sciences, Anhui Medical University, Hefei, China.
- Biopharmaceutical Research Institute, Anhui Medical University, Hefei, China.
- Anhui Provincial Key Laboratory for Brain Bank Construction and Resource Utilization, Anhui Medical University, Hefei, China.
ORCID-Profile: Yuxian Shen
Förderung
- National Natural Science Foundation of China
- Research Fund of Anhui Institute of translational medicine
- Joint Fund of the National Natural Science Foundation of China
Zitieren
APA
Shen, Y., Wang, J., Liang, J., Chen, Y., Wu, X., Ren, Z., Zhou, J., Feng, L., & Shen, Y. (2024). E3 Ubiquitin Ligase Ring Finger Protein 2 Alleviates Cerebral Ischemia–Reperfusion Injury by Stabilizing Mesencephalic Astrocyte‐Derived Neurotrophic Factor Through Monoubiquitination. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.70136
Vancouver
Shen Y, Wang J, Liang J, Chen Y, Wu X, Ren Z, et al. E3 Ubiquitin Ligase Ring Finger Protein 2 Alleviates Cerebral Ischemia–Reperfusion Injury by Stabilizing Mesencephalic Astrocyte‐Derived Neurotrophic Factor Through Monoubiquitination. CNS Neuroscience & Therapeutics. 2024. doi:10.1111/cns.70136
BibTeX
@article{Shen2024,
author = {Shen, Yujun and Wang, Jinfeng and Liang, Junxing and Chen, Ying and Wu, Xueyan and Ren, Zhenhua and Zhou, Jiangning and Feng, Lijie and Shen, Yuxian},
title = {E3 Ubiquitin Ligase Ring Finger Protein 2 Alleviates Cerebral Ischemia–Reperfusion Injury by Stabilizing Mesencephalic Astrocyte‐Derived Neurotrophic Factor Through Monoubiquitination},
journal = {CNS Neuroscience & Therapeutics},
year = {2024},
doi = {10.1111/cns.70136}
}
EUVIMED